Pertinax Pharma

Pertinax Pharma is a specialist pharmaceutical company that has developed a patented technology for the controlled and sustained release of chlorhexidine, a gold-standard antimicrobial agent. Spun out from the University of Bristol in 2014, the company's core innovation allows for the delivery of chlorhexidine over periods ranging from days to years, significantly improving upon traditional formulations that lose efficacy quickly. The technology is highly versatile and is applied in wound care, dentistry, and as a coating for medical devices to prevent healthcare-associated infections. In June 2024, Pertinax Pharma was acquired by Medline Industries, a global leader in healthcare manufacturing and distribution. This acquisition integrates Pertinax's advanced antimicrobial capabilities into Medline's extensive product portfolio.